Pacira BioSciences, Inc.
Income Statement
| Line Item | FY2009 |
|---|---|
| Revenue | $15.0M |
| Cost of Revenue | $12.3M |
| Gross Profit | $2.7M |
| Gross Margin | 18.0% |
| Operating Expenses | |
| Research & Development | $26.2M |
| SG&A Expense | $5.0M |
| Operating Income | $-28.5M |
| Operating Margin | -190.2% |
| Interest Expense | $1.7M |
| Pretax Income | — |
| Income Tax Expense | — |
| Net Income | $-31.7M |
| Net Margin | -211.3% |
| EPS (Basic) | $-55.32 |
| EPS (Diluted) | $-55.32 |
| Shares Outstanding (Basic) | 573.1K |
| Shares Outstanding (Diluted) | 573.1K |
| Dividends Per Share | — |